The Global Tribune

Pancreatic Cancer Pipeline Report, 2022 – Emerging Therapies, Marketed Drugs, Clinical Trials, and Treatment Outlook | Key Companies – BioXcel, Eli Lily, FibroGen, NanOlogy, OSI Pharma, and NantKwest

 Breaking News
  • No posts were found

Pancreatic Cancer Pipeline Report, 2022 – Emerging Therapies, Marketed Drugs, Clinical Trials, and Treatment Outlook | Key Companies – BioXcel, Eli Lily, FibroGen, NanOlogy, OSI Pharma, and NantKwest

June 20
19:15 2022
Pancreatic Cancer Pipeline Report, 2022 - Emerging Therapies, Marketed Drugs, Clinical Trials, and Treatment Outlook | Key Companies - BioXcel, Eli Lily, FibroGen, NanOlogy, OSI Pharma, and NantKwest
Delveinsight Business Research LLP
“Pancreatic Cancer Pipeline Insight, 2022″ report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Pancreatic Cancer Market.

The Pancreatic Cancer Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. 

The report also covers a detailed description of the drug including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers, acquisition, funding, designations, and other product-related details.

Pancreatic Cancer Pipeline Analysis

Pancreatic Cancer Pipeline Analysis

The report provides insights into: 

  • The report provides detailed insights about companies that are developing therapies for the treatment of Pancreatic Cancer with aggregate therapies developed by each company for the same.

  • It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for the Pancreatic Cancer Treatment.

  • Pancreatic Cancer key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.

  • Pancreatic Cancer Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type. 

  • Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement of the Pancreatic Cancer market.

The report is built using data and information traced from the researcher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.  

Request for Sample PDF Report – https://www.delveinsight.com/sample-request/pancreatic-cancer-pipeline-insight

Pancreatic Cancer Therapeutics Landscape

At present several key players are developing therapies in the Pancreatic Cancer market. In the coming years owing to the positive outcomes of the emerging pipeline candidates, along with several others that are under clinical development are expected to transform the Pancreatic Cancer Therapeutics market dynamics. 

Pancreatic Cancer Therapies covered in the report include:

  • EndoTAG-1

  • Masitinib

  • AZD6738

  • NanoPac

  • CPI-613

  • GC4419

  • Pamrevlumab

  • PD-L1 t-hank and N-803

And many more

Some of the key companies in the Pancreatic Cancer Market include:

  • Merck

  • Eli Lily

  • FibroGen

  • AB Science

  • NanOlogy

  • AstraZeneca

  • OSI Pharmaceuticals 

  • NantKwest/ ImmunityBio

  • Rafael Pharmaceuticals 

  • Galera Therapeutics

  • SynCore Biotechnology

  • BioXcel Therapeutics

And others

Get More Detailed Insights Into the Emerging Therapies & Key Companies –    https://www.delveinsight.com/sample-request/pancreatic-cancer-pipeline-insight

Table of Content (TOC)

1. Report Introduction

2. Executive Summary

3. Pancreatic Cancer Current Treatment Patterns

4. Pancreatic Cancer – DelveInsight’s Analytical Perspective

5. Therapeutic Assessment

6. Pancreatic Cancer Late Stage Products (Phase-III)

7. Pancreatic Cancer Mid-Stage Products (Phase-II)

8. Pancreatic Cancer Early Stage Products (Phase-I)

9. Pre-clinical Products and Discovery Stage Products

10. Inactive Products

11. Dormant Products

12. Pancreatic Cancer Discontinued Products

13. Pancreatic Cancer Product Profiles

14. Key Companies in the Pancreatic Cancer Market

15. Key Products in the Pancreatic Cancer Therapeutics Segment

16. Dormant and Discontinued Products

17. Pancreatic Cancer Unmet Needs

18. Pancreatic Cancer Future Perspectives

19. Pancreatic Cancer Analyst Review  

20. Appendix

21. Report Methodology

*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

Download Sample PDF Report – https://www.delveinsight.com/sample-request/pancreatic-cancer-pipeline-insight

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

 

Other Trending Healthcare Reports by DelveInsight

Preeclampsia Market

“Preeclampsia Market” report delivers an in-depth understanding of Preeclampsia, historical and forecasted epidemiology as well as the Preeclampsia market trends, emerging therapies, and key companies operating in the domain.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/